An independent association of Gal-3 with mortality only in post-BAV patients suggests an underlying mechanism that is limited to AS subjects undergoing BAV, i.e., contribution of Gal-3 to development of valve restenosis and subsequent HF recurrence. The gene discussed is LGALS3; the disease is aortic stenosis.